<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>32(1)</volume><submitter>Lapmanee S</submitter><pubmed_abstract>This study presents the development and evaluation of &lt;i>Centella Asiatica&lt;/i> (CA)-loaded transfersomes (CANP) as a novel nanocarrier for transdermal delivery. CANP were prepared using an oil-in-water emulsion method, producing nanoparticles with a size of 135.22 ± 4.80 nm, a polydispersity index of 0.22 ± 0.01, and a zeta potential of -26.13 ± 0.58 mV. Stability tests confirmed consistent physicochemical properties under various storage conditions, with encapsulation efficiencies above 68% for madecassoside and 89% for asiaticoside. &lt;i>Ex vivo&lt;/i> permeation studies using porcine skin showed significantly improved skin penetration compared to liposomes and niosomes, attributed to the high deformability index (1.31 ± 0.21 mg/cm&lt;sup>2&lt;/sup>). &lt;i>In vitro&lt;/i> cytotoxicity assays indicated cell viability above 80% across concentrations. Functionally, CANP reduced nitric oxide production in LPS-stimulated RAW 264.7 cells, demonstrating superior anti-inflammatory effects over native CA. CANP also promoted fibroblast proliferation and collagen production by 91.9% and 213.3% at days 7 and 14, respectively, exceeding vitamin C. Wound healing assays confirmed enhanced fibroblast migration and closure rates similar to fibroblast growth factor. &lt;i>In vivo&lt;/i>, CANP hydrogels accelerated healing, with early fibroblast activity and collagen deposition between days 7-14, supporting epithelial regeneration over 21 days. Compared to controls, they more effectively reduced inflammation and increased dermal growth factor expression. These findings support CANP as a promising transdermal nanocarrier with enhanced skin penetration, anti-inflammatory activity, and regenerative potential. Encapsulating CA into transfersomes boosts its therapeutic efficacy, making it a strong candidate for advanced dermal applications.</pubmed_abstract><journal>Drug delivery</journal><pagination>2563649</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12486451</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Transfersomal delivery of &amp;lt;i&amp;gt;Centella asiatica&amp;lt;/i&amp;gt; promotes efficient excision wound healing in rats.</pubmed_title><pmcid>PMC12486451</pmcid><pubmed_authors>Wongchitrat P</pubmed_authors><pubmed_authors>Suttisintong K</pubmed_authors><pubmed_authors>Phongsupa W</pubmed_authors><pubmed_authors>Lapmanee S</pubmed_authors><pubmed_authors>Bunwatcharaphansakun P</pubmed_authors><pubmed_authors>Khongkow M</pubmed_authors><pubmed_authors>Ruktanonchai U</pubmed_authors><pubmed_authors>Bhubhanil S</pubmed_authors><pubmed_authors>Namdee K</pubmed_authors><pubmed_authors>Asawapirom U</pubmed_authors><pubmed_authors>Maitarad P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Transfersomal delivery of &amp;lt;i&amp;gt;Centella asiatica&amp;lt;/i&amp;gt; promotes efficient excision wound healing in rats.</name><description>This study presents the development and evaluation of &lt;i>Centella Asiatica&lt;/i> (CA)-loaded transfersomes (CANP) as a novel nanocarrier for transdermal delivery. CANP were prepared using an oil-in-water emulsion method, producing nanoparticles with a size of 135.22 ± 4.80 nm, a polydispersity index of 0.22 ± 0.01, and a zeta potential of -26.13 ± 0.58 mV. Stability tests confirmed consistent physicochemical properties under various storage conditions, with encapsulation efficiencies above 68% for madecassoside and 89% for asiaticoside. &lt;i>Ex vivo&lt;/i> permeation studies using porcine skin showed significantly improved skin penetration compared to liposomes and niosomes, attributed to the high deformability index (1.31 ± 0.21 mg/cm&lt;sup>2&lt;/sup>). &lt;i>In vitro&lt;/i> cytotoxicity assays indicated cell viability above 80% across concentrations. Functionally, CANP reduced nitric oxide production in LPS-stimulated RAW 264.7 cells, demonstrating superior anti-inflammatory effects over native CA. CANP also promoted fibroblast proliferation and collagen production by 91.9% and 213.3% at days 7 and 14, respectively, exceeding vitamin C. Wound healing assays confirmed enhanced fibroblast migration and closure rates similar to fibroblast growth factor. &lt;i>In vivo&lt;/i>, CANP hydrogels accelerated healing, with early fibroblast activity and collagen deposition between days 7-14, supporting epithelial regeneration over 21 days. Compared to controls, they more effectively reduced inflammation and increased dermal growth factor expression. These findings support CANP as a promising transdermal nanocarrier with enhanced skin penetration, anti-inflammatory activity, and regenerative potential. Encapsulating CA into transfersomes boosts its therapeutic efficacy, making it a strong candidate for advanced dermal applications.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-04T00:37:06.602Z</modification><creation>2026-05-03T03:13:00.303Z</creation></dates><accession>S-EPMC12486451</accession><cross_references><pubmed>41025315</pubmed><doi>10.1080/10717544.2025.2563649</doi></cross_references></HashMap>